Methylphenidate 10 mg/1 (Methylphenidate CAPSULE, EXTENDED RELEASE) 10 mg/1

Methylphenidate works by inhibiting the reuptake of dopamine and norepinephrine in the brain, increasing their concentrations in the synaptic cleft. This enhances neurotransmission, leading to improved focus, attention, and alertness.

The dosage of Methylphenidate 10 mg/1 is determined by a healthcare professional based on the patient's condition, age, and response to treatment. It is important to follow the prescribed dosage and not to exceed the recommended amount.

Methylphenidate is classified as a Category C drug during pregnancy, meaning it should be used with caution. It is not recommended for use during breastfeeding. Always consult a healthcare professional before using Methylphenidate during pregnancy or breastfeeding.

To order Methylphenidate 10 mg/1 from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will reply with pricing, availability, shipping, and the import paperwork.

Methylphenidate is one of the most commonly prescribed medications for ADHD. It is a central nervous system stimulant that works by increasing the levels of dopamine and norepinephrine in the brain. Compared to other ADHD medications, Methylphenidate has a rapid onset of action and is available in both immediate-release and extended-release formulations.

Methylphenidate 10 mg/1 should be stored at 20° to 25°C (68° to 77°F) in a dry place protected from light and moisture. Keep the medication in its original packaging and out of reach of children.

Methylphenidate 10 mg/1 is administered orally, typically once daily in the morning. The extended-release formulation ensures a steady release of the medication throughout the day. It is important to take the medication as prescribed by a healthcare professional.

The most serious risks associated with Methylphenidate 10 mg/1 include cardiovascular issues such as increased heart rate and blood pressure, psychiatric symptoms such as hallucinations and severe anxiety, and potential growth suppression in children. Regular monitoring by a healthcare professional is essential.

Methylphenidate 10 mg/1 should not be used by individuals with certain medical conditions, such as severe anxiety, agitation, or a history of substance abuse. It is also not recommended for patients with a history of heart disease, high blood pressure, or glaucoma. Always consult a healthcare professional before starting Methylphenidate.